Literature DB >> 15517023

Candidemia in a Brazilian tertiary care hospital: species distribution and antifungal susceptibility patterns.

Ana Graciela Ventura Antunes1, Alessandro Comarú Pasqualotto, María Cristina Diaz, Pedro Alves d'Azevedo, Luiz Carlos Severo.   

Abstract

Recent studies have shown differences in the epidemiology of invasive infections caused by Candida species worldwide. In the period comprising August 2002 to August 2003, we performed a study in Santa Casa Complexo Hospitalar, Brazil, to determine Candida species distribution associated with candidemia and their antifungal susceptibility profiles to amphotericin B, fluconazole and itraconazole. Antifungal susceptibility was tested according to the broth microdilution method described in the NCCLS (M27A-2 method). Only one sample from each patient was analyzed (the first isolate). Most of the episodes had been caused by species other than C. albicans (51.6%), including C. parapsilosis (25.8%), C. tropicalis (13.3%), C. glabrata (3.3%), C. krusei (1.7%), and others (7.5%). Dose-dependent susceptibility to itraconazole was observed in 14.2% of strains, and dose-dependent susceptibility to fluconazole was found in 1.6%. Antifungal resistance was not found, probably related to low use of fluconazole. Further epidemiological surveillance is needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517023     DOI: 10.1590/s0036-46652004000500001

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  14 in total

1.  In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.

Authors:  Ana Carolina Azevedo; Fernando César Bizerra; Daniel Arquimedes da Matta; Leila Paula de Almeida; Robert Rosas; Arnaldo Lopes Colombo
Journal:  Mycopathologia       Date:  2010-12-23       Impact factor: 2.574

2.  Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.

Authors:  Arnaldo L Colombo; Marcio Nucci; Benjamin J Park; Simone A Nouér; Beth Arthington-Skaggs; Daniel A da Matta; David Warnock; Juliette Morgan
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  A 9-year study comparing risk factors and the outcome of paediatric and adults with nosocomial candidaemia.

Authors:  A C Pasqualotto; W L Nedel; T S Machado; L C Severo
Journal:  Mycopathologia       Date:  2005-09       Impact factor: 2.574

4.  Evaluation of antifungal susceptibility testing with microdilution and Etest methods of Candida blood isolates.

Authors:  Dilek Yesim Metin; Suleyha Hilmioglu-Polat; Pinar Samlioglu; Biray Doganay-Oflazoglu; Ramazan Inci; Emel Tumbay
Journal:  Mycopathologia       Date:  2011-03-20       Impact factor: 2.574

5.  Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.

Authors:  Xisto Sena Passos; Carolina Rodrigues Costa; Crystiane Rodrigues Araújo; Elisa Sales Nascimento; Lúcia Kioko Hasimoto e Souza; Orionalda de Fátima Lisboa Fernandes; Werther Souza Sales; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2007-03-01       Impact factor: 2.574

6.  International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

Authors:  L Ostrosky-Zeichner; D Kontoyiannis; J Raffalli; K M Mullane; J Vazquez; E J Anaissie; J Lipton; P Jacobs; J H Jansen van Rensburg; J H Rex; W Lau; D Facklam; D N Buell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-10       Impact factor: 3.267

7.  Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain.

Authors:  R Cisterna; G Ezpeleta; O Telleria; J Guinea; B Regueiro; J Garcia-Rodríguez; J Esperalba
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

8.  Candidaemia and cancer: patients are not all the same.

Authors:  Alessandro Comarú Pasqualotto; Daniela Dornelles Rosa; Lidia Rosi Medeiros; Luiz Carlos Severo
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

9.  Epidemiology of candidemia in Latin America: a laboratory-based survey.

Authors:  Marcio Nucci; Flavio Queiroz-Telles; Tito Alvarado-Matute; Iris Nora Tiraboschi; Jorge Cortes; Jeannete Zurita; Manuel Guzman-Blanco; Maria Elena Santolaya; Luis Thompson; Jose Sifuentes-Osornio; Juan I Echevarria; Arnaldo L Colombo
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Clinical significance of the isolation of Candida species from hospitalized patients.

Authors:  Yankee C Magalhães; Maria Rosa Q Bomfim; Luciane C Melônio; Patrícia C S Ribeiro; Lécia M Cosme; Cristianne R Rhoden; Sirlei G Marques
Journal:  Braz J Microbiol       Date:  2015-03-31       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.